Literature DB >> 7054120

N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.

F E Dewhirst.   

Abstract

N-Acetyl-muramyl-L-alanyl-D-isoglutamine (MDP), a structurally defined fragment of bacterial peptidoglycan, stimulated significant release of previously incorporated 45Ca from fetal rat bones in tissue culture over the concentration range of 0.1 to 10.0 micrograms/ml. MDP-Stimulated bone resorption was not inhibited by the addition of the prostaglandin synthetase inhibitor indomethacin to the culture medium. MDP was neither mitogenic for nor stimulated the release of osteoclast-activating factor from cultured human peripheral blood mononuclear cells. Thus, MDP-stimulated bone resorption in vitro is mediated by a mechanism which is not dependent upon prostaglandins or osteoclast-activating factor. 6-O-Stearoyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine, a lipophilic analog of MDP, was slightly more potent than MDP. Two diastereomers of MDP, N-acetyl-muramyl-L-alanyl-L-isoglutamine and N-acetyl-muramyl-D-alanyl-D-isoglutamine, which are inactive as adjuvants, were at least 1,000 times less active than MDP in stimulating bone resorption. The stereochemical specificity for bone-resorptive activity paralleled that required for adjuvant activity, macrophage activation, and activation of the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054120      PMCID: PMC351006          DOI: 10.1128/iai.35.1.133-137.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Structural requirements for bone resorption by endotoxin and lipoteichoic acid.

Authors:  E Hausmann; O Lüderitz; K Knox; N Weinfeld
Journal:  J Dent Res       Date:  1975-06       Impact factor: 6.116

2.  Release of osteoclast activating factor by normal human peripheral blood leukocytes.

Authors:  C L Trummel; G R Mundy; L G Raisz
Journal:  J Lab Clin Med       Date:  1975-06

3.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

Review 4.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

Review 5.  Bone resorption in tissue culture and its relevance to periodontal disease.

Authors:  P Goldhaber; L Rabadjija; W R Beyer; A Kornhauser
Journal:  J Am Dent Assoc       Date:  1973-10       Impact factor: 3.634

6.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor.

Authors:  J E Horton; J J Oppenheim; S E Mergenhagen; L G Raisz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

7.  Mitogenic effect of bacterial peptidoglycans possessing adjuvant activity.

Authors:  C Damais; C Bona; L Chedid; J Fleck; C Nauciel; J P Martin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

8.  Complement-dependent stimulation of prostaglandin synthesis and bone resorption.

Authors:  L G Raisz; A L Sandberg; J M Goodson; H A Simmons; S E Mergenhagen
Journal:  Science       Date:  1974-08-30       Impact factor: 47.728

9.  Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria.

Authors:  S Kotani; T Narita; D E Stewart-Tull; T Shimono; Y Watanabe
Journal:  Biken J       Date:  1975-06

10.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06
View more
  9 in total

Review 1.  Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?

Authors:  J Ciampolini; K G Harding
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

4.  Role of Porphyromonas gingivalis-derived fibroblast-activating factor in bone resorption.

Authors:  J Mihara; T Yoneda; S C Holt
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  The effect of lipopolysaccharide from bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase release.

Authors:  H J Sismey-Durrant; S J Atkinson; R M Hopps; J K Heath
Journal:  Calcif Tissue Int       Date:  1989-05       Impact factor: 4.333

6.  Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida.

Authors:  T G Kimman; C W Löwik; L J van de Wee-Pals; C W Thesingh; P Defize; E M Kamp; O L Bijvoet
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Bacterial flora in spontaneously occurring aural cholesteatomas in Mongolian gerbils.

Authors:  R S Fulghum; R A Chole
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Dependence of proliferation of Bacteroides forsythus on exogenous N-acetylmuramic acid.

Authors:  C Wyss
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

9.  Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.

Authors:  T Ikebe; M Hirata; F Yanaga; T Koga
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.